MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AFTER POST-TRANSPLANT HEPATOCELLULAR CARCINOMA RECURRENCE: IS IT TOO LATE?

被引：0
|
作者：
Au, Kin Pan [1 ]
Chok, Kenneth Siu Ho [1 ]
机构：
[1] Univ Hong Kong, Surg, Hong Kong, Peoples R China
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-18.26
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 50 条
  • [31] Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation?
    Cholongitas, Evangelos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (01) : 116 - 117
  • [32] An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma
    Jian-Wen Cheng
    Ying-Hong Shi
    Jia Fan
    Xiao-Wu Huang
    Shuang-Jian Qiu
    Yong-Sheng Xiao
    Zheng Wang
    Zhi Dai
    Zhao-You Tang
    Jian Zhou
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1445 - 1453
  • [33] Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues
    Marrone, Giuseppe
    Leone, Maria Sandrina
    Biolato, Marco
    Liguori, Antonio
    Bianco, Giuseppe
    Spoletini, Gabriele
    Gasbarrini, Antonio
    Miele, Luca
    Pompili, Maurizio
    CANCERS, 2023, 15 (23)
  • [34] Mammalian Target of Rapamycin Inhibitors and Survival in Heart Transplant Recipients
    Jennings, Douglas L.
    Lange, Nicholas
    Shullo, Michael
    Baker, William L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (24) : 2859 - 2860
  • [35] Hepatocellular Carcinoma-Recurrence Risk Index May Predict Post-Transplant Hepatocellular Carcinoma Recurrence Better Than Milan Criteria
    Sharma, Pratima
    Byrne, Thomas
    Welch, Kathy
    Amir, Yosephy
    Vargas, Hugo
    Marrero, Jorge
    Merion, Robert
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 451 - 451
  • [36] Factors predicting survival after post-transplant hepatocellular carcinoma recurrence (vol 20, pg 342, 2013)
    Toso, Christian
    Cader, Sonia
    Mentha-Dugerdil, Ariane
    Meeberg, Glenda
    Majno, Pietro
    Morard, Isabelle
    Giostra, Emiliano
    Berney, Thierry
    Morel, Philippe
    Mentha, Gilles
    Kneteman, Norman M.
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2013, 20 (05) : 547 - 548
  • [37] PREDICTORS OF POST-TRANSPLANT RECURRENCE OF HEPATOCELLULAR CARCINOMA BASED ON EXPLANT ANALYSIS: A MULTICENTER STUDY
    Pai, Suraj
    Hayat, Muhammad Hashim
    Rao, Joseph Sushil
    Bouquet, Erin
    Ziogas, Ioannis
    Borgmann, Anthony
    Anbari, Hassan
    Slaughter, Christopher
    Adeyi, Oyedele A.
    Alexopoulos, Sophoclis
    Parikh, Neehar Dilip
    Kirchner, Varvara A.
    Izzy, Manhal
    HEPATOLOGY, 2023, 78 : S1875 - S1875
  • [38] Post-Transplant Recurrence Following Yttrium-90 Treatment in Liver Transplant Recipients with Hepatocellular Carcinoma
    Rizzo, O.
    Kitajima, T.
    Kavousi, M.
    Yeddula, S.
    Rizzari, M.
    Collins, K.
    Yoshida, A.
    Abouljoud, M. S.
    Nagai, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1057 - 1057
  • [39] Peri-Operative Basiliximab is Not Associated with Post-Transplant Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
    Salerno, D.
    Lange, N.
    Simoneau, E.
    Sammons, C.
    Bley, D.
    Brown, R. S., Jr.
    Emond, J.
    Halazun, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1071 - 1072
  • [40] Activation of the Mammalian Target of Rapamycin Signaling Pathway in Hepatocellular Carcinoma
    Subbiah, Ishwaria M.
    Brown, Robert E.
    Fallon, Michael B.
    HEPATOLOGY, 2010, 52 (04) : 1524 - 1524
12345